Form 6-K BRIGHT MINDS BIOSCIENCES For: Sep 08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2021
Commission File No. 000-56296
BRIGHT MINDS BIOSCIENCES INC.
(Translation of registrant's name into English)
1500 - 1055 West Georgia St.
Vancouver, British Columbia, Canada, V6E 4N7
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]
SUBMITTED HEREWITH
Exhibits | |
99.1 | News Release dated September 8, 2021 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BRIGHT MINDS BIOSCIENCES INC. | |
/s/ Ryan Cheung | |
Ryan Cheung | |
Chief Financial Officer |
Date: September 16, 2021
Bright Minds Biosciences to Present at the Virtual H.C. Wainwright 23rd Annual
Global Investment Conference; Shares Now Eligible for DTC Clearance
VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences ("Bright Minds," "BMB" or the "Company") (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, and Dr. Alan Kozikowski PhD, Chief Scientific Officer, will be presenting virtually at the H.C. Wainwright 23rd Annual Global Investment Conference as follows:
Date: Monday, September 13, 2021
Time: On demand, beginning at 7:00AM Eastern Time
Webcast: https://journey.ct.events/view/7cb12265-78b5-4407-87f7-e41271254ecf
The webcast will be available for 90 days under the "Investors" section of the Bright Minds website, www.brightmindsbio.com.
The Company also announced that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States. The DTC is the largest securities depository in the world and facilitates electronic settlement of stock certificate transfers in the United States. The shares of the Company, trading on the OTCQB under the symbol "BMBIF," are now eligible to be electronically cleared and settled through the DTC and are therefore considered "DTC eligible." This electronic method of clearing securities accelerates the settlement process for investors and brokers. DTC eligibility is expected to simplify the process of trading and enhance liquidity for the Company's common shares.
About Bright Minds
Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy and pain. Bright Minds has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The Company leverages its world-class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs. Bright Minds' drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Investor Contact:
Judy DiClemente
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- La Rosa Regains Compliance with Nasdaq
- Hay Company From Oregon Featured on FT List of Rapidly Growing Companies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!